PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 66 | 08 |

Tytuł artykułu

Związki hormonalne aktywne w środowisku a zagrożenia zdrowia publicznego

Warianty tytułu

EN
Hormonally active compounds in the environment and public health implications

Języki publikacji

PL

Abstrakty

EN
This article is a review of recently published papers dealing with the possible participation of environmental hormonally active compounds (natural and synthetic) in the ethiology of reproductive and other health disorders in animals and man. For some "old" synthetic chemicals (DDT, PCBs, dioxins, diethylstilbestrol, bisphenol A, atrazine and tributyltin) there is a link to the impact on wild animals. It has been hypothesized that in humans these compounds may be responsible for the increased incidence of breast and testicular cancer as well as for reproductive disorders. They generally occur at nontoxic concentrations, but exposure to their mixtures seems to be a major medical challenge. The food and drinking water are the main routes of exposure. During last decades much concern is focused on new groups of chemicals such as brominated flame retardants, phthalates, perfluorinated chemicals, parabens and veterinary drugs (anabolics).

Wydawca

-

Rocznik

Tom

66

Numer

08

Opis fizyczny

s.525-529,tab.,bibliogr.

Twórcy

autor
  • Zakład Farmakologii i Toksykologii Państwowego Instytutu Weterynaryjnego - Państwowego Instytutu Badawczego, Al.Partyzantów 57, 24-100 Puławy

Bibliografia

  • 1. Adams N. R.: Clover phyto-oestrogens in sheep in Western Australia. Pure Appl. Chem. 1998, 70, 1855-1862.
  • 2. Andersson A.-M., Skakkebaek N. E.: Exposure to exogenous estrogens in food: possible impact on human development and health. Eur. J. Endocrinol. 1999, 140, 477-485.
  • 3. Apelberg B. J., Witter F. R., Herbstman J. B.: Cord serum concentrations ofperfluorrctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ. Health Perspect. 2007, 115, 1670-1676.
  • 4. Brody J. G., Rudel R. A.: Environmental pollutants and breast cancer. Environ. Health Perspect. 2003, 111, 1007-1019.
  • 5. Charles G. D., Linscombe V. A., Tornesi B., Mattson J. L., Gollapudi B. B.: An in vitro screening paradigm for extracts of whole foods for detection of potential toxicants. Food Chem. Toxicol. 2002, 40, 1391-1402.
  • 6. Daniels J. L., Jen-Pan I., Jones R., Anderson S., Patterson D. G., Needham L. L., Sjödin A.: Individual characteristics associated with PBDE levels in U.S. human milk samples. Environ. Health Perspect. 2010, 118, 155-160.
  • 7. Daughton C. G., Ternes T. A.: Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ. Health Perspect. 1999, 107 (suppl. 6), 907-938.
  • 8. Diekman M. A., Green M. L.: Mycotoxins and reproduction in domestic livestock. J. Anim. Sci. 1992, 70, 1615-1627.
  • 9. Ericson I., Marti-Cid R., Nadal M., Van Bavel B., Lindström G., Domingo J. L.: Human exposure to perfluorinated chemicals through the diet: intake of perfluorinated compounds in food from the Catalan (Spain) market. Agric. Food Chem. 2008, 56, 1787-1794.
  • 10. Falandysz J.: Butylocyna i produkty jej degradacji w aspekcie toksykologii żywności. Rocz. Państw. Zakł. Hig. 2003, 54, 13-23.
  • 11. Fernandez M. F., Molina-Molina J. M., Lopez-Espinosa M.-J. Freire C., Campoy C., Ibarluzea J., Torne P., Pedraza V., Olea N.: Biomonitoring of environmental estrogens in human tissues. Int. J. Hyg. Environ. Health 2007, 210, 429-432.
  • 12. Filby A. L., Neuparth T., Thorpe K. L., Owen R., Galloway T. S., Tyler C. R.: Health impact of estrogens in the environment, considering complex mixture effects. Environ. Health Perspect. 2007, 115, 1704-1710.
  • 13. Gill W. B., Schumacher G. F. B., Bibbo M., Sraus F. H. I., Schoenberg H. W.: Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J. Urol. 1979, 122, 36-39.
  • 14. Giwerman A., Rylander L., Hagmar L., Giwermann Y. L.: Ethnic differences in occurence of TDS-genetics and/or environment. Int. J. Androl. 2006, 29, 291-297.
  • 15. Halling-Sorensen B., Nielsen S. N., Lanzky P. F., Ingerslev F., Holten Lützheft H. C., Jørgensen S. E.: Occurrence, fate and effects of pharmaceutical substances in the environment - a review. Chemosphere 1998, 36, 357-393.
  • 16. Hansen C., Luben T. J., Sacs J. D. Olshan A., Jeffay S., Strader L., Perreault S. D.: The effect of ambient air pollution on sperm quality. Environ. Health Perpect. 2010, 118, 203-209.
  • 17. Herbst A. L., Ulfelder H., Poskanzer D. C.: Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med. 1971, 284, 878-881.
  • 18. Hotchkiss A. K., Rider C. V., Blystone C. R., Wilson V. S., Hartig P. C., Ankley G. T., Foster P. M., Gray C. G., Gray L. E.: Fifteen years after "Wing-spread" - environmental endocrine disrupters and human and wildlife health: where wee are today and where we need to go. Toxicol. Sci. 2008, 105, 235-259.
  • 19. Ingerslev F., Vaclavik E., Halling-Sorensen B.: Pharmaceuticals and personal care products: a source of endocrine disruption in the environment? Pure Appl. Chem. 2003, 75, 1881-1889.
  • 20. Jobling S., Reynolds T., White R., Parker M. G., Sumpter J. P.: A variety of environmentally persistent chemicals, including some phthalate plasticizers are weakly estrogenic. Environ. Health Perspect. 1995, 103, 582-587.
  • 21. Joffe M.: What has happened to human fertility? Hum. Reprod. 2010, 25, 295-307.
  • 22. Laws S. C., Ferrell J. M., Stoker T. E., Schmid J., Cooper R. L.: The effects of atrazine on female Wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol. Sci. 2000, 58, 366-376.
  • 23. Lenkowski J. R., Reed J. M., Deininger L., McLaughlin K. A.: Perturbation of organogenesis by herbicide atrazine in the amphibian Xenopus laevis. Environ. Health Perspect. 2008, 116, 223-230.
  • 24. Martin O. V., Lester J. N., Voulvoulis N., Boobis A. R.: Human health and endocrine disruption: a simple multicriteria frame work for qualitative assessment of end point-specific risks in context of scientific uncertainty. Toxicol. Sci. 2007, 98, 332-347.
  • 25. McLachlan J. A., Simpson E., Martin M.: Endocrine disrupters and female reproductive health. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20, 63-75.
  • 26. Mendes J. J. A.: The endocrine disrupters: a major medical challenge. Food Chem. Toxicol. 2002, 40, 781-788.
  • 27. Nilsson R.: Endocrine modulators in the food chain and environment. Toxicol. Pathol. 2000, 28, 420-431.
  • 28. Olsen G. W., Butenhoff J. L., Nobel L. R.: Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27, 212-230.
  • 29. Peden-Adams M. M., Stuckey J. E., Gaworecki K. M., Berger-Ritchie J., Bryant K., Jodice P. G., Scott T. R., Ferrario J. B., Guan B., Vigo C., Boone J. S., Mc-Guin W. D., DeWitt J. C., Keil D. E.: Developmental toxicity in white leghorn chickens following in ovo exposure to perfluorooctane sulfonate (PFOS). Reprod. Toxicol. 2009, 27, 307-318.
  • 30. Rosano A., Botto L. D., Botting B., Mastroiacovo P.: Infant mortality and congenital anomalies from 1950 to 1994: an international perspective. J. Epidemiol. Community Health 2000, 54, 660-666.
  • 31. Rosselli M., Reinhart K., Imthurn B., Keller P. J., Dubey R. K.: Cellular and biochemical mechanisms by which environmental oestrogens influence reproductive function. Hum. Reprod. Update 2000, 6, 332-350.
  • 32. Roy J. R., Chakraborty S., Chakraborty T. R.: Estrogen-like endocrine disrupting chemicals affecting puberty in humans – a review. Med. Sci. Monit. 2009, 15, RA137-145.
  • 33. Safe S.: Endocrine disruptors and human health - is there a problem? An update. Environ. Health Perspect. 2000, 108, 487-493.
  • 34. Seegal R. F.: The neurotoxicological consequences of developmental exposure to PCBs. Toxicol. Sci. 2000, 57, 1-3.
  • 35. Sekizawa J.: Low-dose effects of bisphenol A: a serious threat to human health? J. Toxicol. Sci. 2008, 33, 389-403.
  • 36. Skakkebaek N. E., Rajpert-De Myets K. M.: Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum. Reprod. 2001, 16, 972-978.
  • 37. Stoker T. E., Laws S. C., Guidici D. L., Cooper R. L.: The effect of atrazine on puberty in male wistar rats: an evaluation in the protocol for the assessment of pubertal development and thyroid function. Toxicol. Sci. 2000, 58, 50-59.
  • 38. Storgaard L., Bonie J. P., Olsen J.: Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod. Toxicol. 2006, 21, 4-15.
  • 39. Struciński P., Góralczyk K., Ludwicki J. K., Czaja K., Hernik A., Korcz W.: Levels of selected organochlorine insecticides, polychlorinated biphenyls, phthalates and perfluorinated aliphatic substances in blood-Polish WWF study. Roczn. PZH 2006, 57, 99-112.
  • 40. Struciński P., Ludwicki J. K., Góralczyk K., Czaja K.: Wybrane aspekty działania ksenoestrogenów z grupy persystentnych związków chloroorganicznych. Rocz. Państw. Zakł. Hig. 2000, 51, 211-228.
  • 41. Suja F., Pramanik B. K., Zain S. M.: Contamination, bioaccumulation and tonic effects of perfluorinated chemicals (PFCs) in water environment: a review paper. Water Sci. Technol. 2009, 60, 1533-1544.
  • 42. Swan S. H., Main K. M., Liu F., Stewart S. L., Kruse R. L., Calafat A. M., Mao C. S., Redmon J. B., Ternand C. L., Sullivan S., Teague J. L.: Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 2005, 113, 1056-1061.
  • 43. Talsness C. E., Kuriyama S. N., Sterner-Kock A., Schnitker P., Grande S. W., Shakibaei M., Andrade A., Grote K., Chahoud I.: In utero and lactational exposures to low doses of polybrominated diphenyl ether-47 alter the reproductive system and thyroid gland of female rat offspring. Environ. Health Perspect. 2008, 116, 308-314.
  • 44. Verger P., Leblanc J. C.: Concentration of phytohormones in food and feed and their impact on the human exposure. Pure Appl. Chem. 2003, 75, 1873-1880.
  • 45. Villanueva C. M., Durand G., Coutté M.-B., Chevrie C., Cordie S.: Atrazine in municipal drinking water and risk of low birth weight, preterm delivery and small-for-gestational-age status. Occup. Environ. Med. 2005, 62, 400-405.
  • 46. Wanibuchi H., Kang J. S., Salim E. I., Morimura K., Fukushima S.: Toxicity vs. beneficial effects of phytoestrogens. Pure Appl. Chem. 2003, 75, 2047-2053.
  • 47. Waring R. H., Harris R. M.: Endocrine disrupters: a human risk? Mol. Cell. Endocrinol. 2005, 244, 2-9.
  • 48. Wigle D. T., Arbucle T. E., Walker M., Wade M. G., Liu S., Krewski D.: Environmental hazards: evidence for effects on child health. J. Toxicol. Environ. Health B Crit. Rev. 2007, 10, 3-39.
  • 49. Wilson C. A., Davies D. C.: The control of sexual differentiation of the reproductive system and brain. Reproduction 2007, 133, 331-359.
  • 50. Winchester P. D., Huskins J., Ting J.: Agrichemicals in surface water and birth defects in the United State. Acta Paediatr. 2009, 98, 664-669.
  • 51. Wiśniewska-Dmytrow H., Kozak A., Żmudzki J.: Occurence of Fusarium mycotoxins in feedstuffs from farms with husbandry problems. Bull. Vet. Inst. Pulawy 2004, 48, 117-122.
  • 52. Witorsch R. J.: Endocrine disruptors: can biological effects and environmental risks be predicted? Regul. Toxicol. Pharmacol. 2002, 36, 118-130.
  • 53. Żmudzki J.: Kontrola pozostałości chemicznych w tkankach zwierząt i żywności - ważny element w ochronie zdrowia publicznego. Post. Nauk Rol. 2008, 2, 49-59.

Uwagi

Rekord w opracowaniu

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.dl-catalog-fb4265f3-dd8a-4747-8517-e199653ca719
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.